<DOC>
	<DOCNO>NCT02420626</DOCNO>
	<brief_summary>The Crux Vena Cava Filter ( VCF ) Registry clinical study , sponsor Volcano Corporation , evaluate short long term performance clinical outcome Crux Vena Cava Filter System .</brief_summary>
	<brief_title>Evaluation Short Long Term Performance Clinical Outcomes Crux Vena Cava Filter System</brief_title>
	<detailed_description>The Crux VCF Registry non-randomized clinical study , sponsor Volcano Corporation , evaluate short long term performance clinical outcome Crux VCF System . The registry include consecutive patient treat Crux VCF post-market ( commercial ) set data collection implant procedure 2 year post implant filter retrieval , whichever come first . Patients may also enrol ( roll-in ) previous Crux VCF implant within previous 6 month . Follow assessment perform 6 , 12 24 month post-implant time retrieval , perform .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>1 . The patient &gt; 18 year age . 2 . Patient legally authorize representative understands research nature study willing capable providing inform consent . 3 . Scheduled receives Crux VCF implant ; 4 . Have previously Crux VCF implant within previous 6 month . 1 . Patient schedule filter implant , Crux VCF filter implant due anatomical exclusion technical failure . 2 . Patients unwilling unable comply protocol provide inform consent . 3 . Female patient childbearing potential pregnant ( must negative pregnancy test within 48 hour prior implantation retrieval procedure ) 4 . Patient participate another device drug clinical trial interferes protocol follow schedule .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>